HPV Status Determines the Efficacy of Adjuvant Chemotherapy With S-1, an Oral Fluorouracil Prodrug, in Oropharyngeal Cancer.

@article{Wakisaka2015HPVSD,
  title={HPV Status Determines the Efficacy of Adjuvant Chemotherapy With S-1, an Oral Fluorouracil Prodrug, in Oropharyngeal Cancer.},
  author={Naohiro Wakisaka and Shinya Yoshida and Satoru Kondo and Makiko Kita and Kazuhira Endo and Akira Tsuji and Shigeyuki Murono and Masamichi Muramatsu and Tomokazu Yoshizaki},
  journal={The Annals of otology, rhinology, and laryngology},
  year={2015},
  volume={124 5},
  pages={400-6}
}
OBJECTIVES A subgroup of oropharyngeal squamous cell carcinoma (OPC) is infected with high-risk human papillomavirus (HPV). The object of this study is to evaluate the efficacy of adjuvant chemotherapy with S-1, an oral 5-fluorouracil prodrug, on survival of patients with OPC according to HPV status. METHODS Among OPC patients of stage III or IV who… CONTINUE READING